Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ECHOMARKETING Co.,Ltd. Global agency accelerating sales with data-driven, full-funnel digital marketing.	South Korea	230360
Eezy Oyj HR services firm for the full employment lifecycle, from recruitment to freelancer support.	Finland	EEZY
Elicio Therapeutics, Inc. Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.	United States of America	ELTX
enCore Energy Corp. American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.	United States of America	EU
ENERGY FUELS INC A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.	United States of America	UUUU
ENIGMATIG LTD Global expansion and regulatory compliance consultancy for the financial services industry.	United States of America	EGG
Enjin Co., Ltd. PR firm for SMEs and medical institutions, offering consulting and a media matching platform.	Japan	7370
Ensol Biosciences Inc. Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.	South Korea	140610
Enveric Biosciences, Inc. Develops novel neuroplastogen drugs for severe mental health and addiction disorders.	United States of America	ENVB
Eutilex Co.,Ltd. Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.	South Korea	263050